Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Net Issuance of Common Stock Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Net Issuance of Common Stock
AU$14.6m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Net Issuance of Common Stock
-AU$10.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Issuance of Common Stock
AU$4.2m
CAGR 3-Years
-41%
CAGR 5-Years
9%
CAGR 10-Years
-17%
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Issuance of Common Stock
AU$100.9m
CAGR 3-Years
N/A
CAGR 5-Years
179%
CAGR 10-Years
39%
Probiotec Ltd
ASX:PBP
Net Issuance of Common Stock
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Net Issuance of Common Stock
-AU$178k
CAGR 3-Years
N/A
CAGR 5-Years
-56%
CAGR 10-Years
-7%

See Also

What is Arovella Therapeutics Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
14.6m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Net Issuance of Common Stock amounts to 14.6m AUD.

What is Arovella Therapeutics Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
13%

Over the last year, the Net Issuance of Common Stock growth was 167%. The average annual Net Issuance of Common Stock growth rates for Arovella Therapeutics Ltd have been 14% over the past three years , 13% over the past five years .

Back to Top